Ultrasound-derived VAT is more strongly associated with hepatic steatosis and metabolic dysfunction than BMI or waist circumference among adults at risk for MASLD.
As these systems evolve, I believe therapeutic ultrasound is poised to become medicine's next general-purpose platform.